MRK DE0006599905

Report

Real-time Estimate Tradegate - 02:15 2022-08-10 pm EDT
187.53	EUR		+1.92%

08/09	MilliporeSigma Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform	AQ
08/05	MERCK Kommanditgesellschaft auf Aktien Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
08/05	MERCK KGAA : Buy rating from Credit Suisse	MD

Calendar

Event chart MERCK KGAA

Upcoming events on MERCK KGAA

10/06/22		Capital Markets Day
11/10/22 \| 01:00am		Q3 2022 Earnings Release
11/10/22 \| 08:00am		Q3 2022 Earnings Call
03/02/23		FY 2022 Earnings Call
03/02/23 \| 01:00am		FY 2022 Earnings Release
04/28/23		Annual General Meeting
05/11/23		Q1 2023 Earnings Call
05/11/23 \| 01:00am		Q1 2023 Earnings Release
08/03/23		Interim 2023 Earnings Release (Projected)
11/09/23		Q3 2023 Earnings Release (Projected)

Past events on MERCK KGAA

08/04/22 \| 08:00am		Interim 2022 Earnings Call
08/04/22 \| 01:00am		Interim 2022 Earnings Release
05/12/22 \| 08:00am		Q1 2022 Earnings Call
05/12/22 \| 01:00am		Q1 2022 Earnings Release
04/25/22		Ex-dividend day for final dividend
04/22/22 \| 04:00am		Annual General Meeting
03/03/22 \| 08:00am		FY 2021 Earnings Call
03/03/22 \| 01:00am		FY 2021 Earnings Release
01/11/22		JP Morgan Healthcare Conference
11/22/21 \| 08:00am		R&D Day

Past dividends on MERCK KGAA

04/25/22		Annual 1.85 EUR
04/26/21		Annual 1.4 EUR
05/29/20		Annual 1.3 EUR
04/29/19		Annual 1.25 EUR
04/30/18		Annual 1.25 EUR
05/02/17		Annual 1.2 EUR
05/02/16		Annual 1.05 EUR
04/20/15		Annual 1 EUR
05/12/14		Annual 1.9 EUR
04/29/13		Annual 1.7 EUR

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M €	Released Forecast Spread	15 327 15 333 -0,04%	14 836 14 756 0,55%	16 152 16 092 0,37%	17 534 17 407 0,73%	19 687 19 632 0,28%	22 136
Operating income (EBITDA) M €	Released Forecast Spread	4 414 4 425 -0,26%	3 800 3 835 -0,91%	4 385 4 335 1,2%	5 201 5 081 2,4%	6 103 6 096 0,12%	6 912
Operating profit (EBIT) M €	Released Forecast Spread	2 525 2 651 -4,8%	1 727 1 981 -13%	2 120 2 262 -6,3%	2 985 2 985 -0,01%	4 179 4 150 0,69%	5 006
Pre-Tax Profit (EBT) M €	Released Forecast Spread	2 224 2 386 -6,8%	1 461 1 725 -15%	1 735 1 928 -10,0%	2 630 2 726 -3,5%	3 924 3 886 0,97%	4 797
Net income M €	Released Forecast Spread	2 600 1 785 46%	3 374 3 306 2,0%	1 320 1 448 -8,9%	1 987 1 999 -0,57%	3 055 2 986 2,3%	3 715
EPS €	Released Forecast Spread	5,98 4,21 42%	7,76 7,14 8,6%	3,04 3,36 -9,5%	4,57 4,62 -1,1%	7,03 6,89 2,1%	8,57
Announcement Date		03/08/2018	03/07/2019	03/05/2020	03/04/2021	03/03/2022	-

Quarterly results

Fiscal Period : December

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q3

Sales
M €

Released
Forecast
Spread

4 870
4 776
2,0%

4 973
4 964
0,18%

5 213
5 172
0,80%

5 198
5 218
-0,38%

5 568
5 417
2,8%

5 540

Operating income
(EBITDA)
M €

Released
Forecast
Spread

1 576
1 476
6,8%

1 552
1 540
0,77%

1 464
1 452
0,82%

1 629
1 631
-0,15%

1 782
1 709
4,3%

1 780

Operating profit
(EBIT)
M €

Released
Forecast
Spread

1 049
1 097
-4,4%

1 047
1 113
-5,9%

1 039
1 138
-8,7%

1 173
1 198
-2,1%

1 177
1 248
-5,7%

1 334

Pre-Tax Profit
(EBT)
M €

Released
Forecast
Spread

955
1 036
-7,9%

993
1 080
-8,1%

992
1 083
-8,4%

1 139
1 131
0,74%

1 122
1 207
-7,1%

1 197

Net income
M €

Released
Forecast
Spread

745
787
-5,4%

761
783
-2,8%

802
812
-1,2%

880
880
0,02%

867
931
-6,9%

950

EPS

Released
Forecast
Spread

1,71
1,81
-5,5%

1,75
1,80
-2,8%

1,84
1,84
0,26%

2,02
2,02
-0,16%

1,99
2,13
-6,6%

2,18

Announcement Date

08/05/2021

11/11/2021

03/03/2022

05/12/2022

08/04/2022

Previous year

Next Year

Upcoming sector events for MERCK KGAA

08/19/22		SK BIOPHARMACEUTICALS CO., LTD. : Interim 2022 Earnings Release (Projected)
08/25/22		BETTA PHARMACEUTICALS CO., LTD. : Interim 2022 Earnings Release
10/28/22		BETTA PHARMACEUTICALS CO., LTD. : Q3 2022 Earnings Release (Projected)
11/04/22		KYOWA KIRIN CO., LTD. : Q3 2022 Earnings Release
11/17/22		SK BIOPHARMACEUTICALS CO., LTD. : Q3 2022 Earnings Release (Projected)
11/29/22		DOTTIKON ES HOLDING AG : Interim 2023 Earnings Release
02/07/23		SK BIOPHARMACEUTICALS CO., LTD. : FY 2022 Earnings Release (Projected)
02/08/23		KYOWA KIRIN CO., LTD. : FY 2022 Earnings Release (Projected)
04/26/23		BETTA PHARMACEUTICALS CO., LTD. : Q1 2023 Earnings Release (Projected)
04/26/23		BETTA PHARMACEUTICALS CO., LTD. : FY 2022 Earnings Release (Projected)

More events

Past sector events for MERCK KGAA

08/04/22		KYOWA KIRIN CO., LTD. : Interim 2022 Earnings Release
05/31/22		DOTTIKON ES HOLDING AG : FY 2022 Earnings Release
05/16/22		SK BIOPHARMACEUTICALS CO., LTD. : Q1 2022 Earnings Release
05/10/22		KYOWA KIRIN CO., LTD. : Q1 2022 Earnings Release
04/27/22		BETTA PHARMACEUTICALS CO., LTD. : Q1 2022 Earnings Release
03/29/22		BETTA PHARMACEUTICALS CO., LTD. : FY 2021 Earnings Release
02/08/22		SK BIOPHARMACEUTICALS CO., LTD. : FY 2021 Earnings Release
02/07/22 \| 01:30am		KYOWA KIRIN CO., LTD. : FY 2021 Earnings Release
11/26/21		DOTTIKON ES HOLDING AG : Interim 2022 Earnings Release
11/01/21		KYOWA KIRIN CO., LTD. : Q3 2021 Earnings Release

More events

Analysis

Merck KGaA's adjusted earnings boosted by strong dollar